Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Arenavirus envelope glycoprotein complex, commonly known as GP-C, is a viral surface protein essential for virus attachment and membrane fusion during host cell entry. It comprises three noncovalently associated subunits: GP1 (receptor binding), GP2 (membrane fusion), and a unique stable signal peptide (SSP; ~58 amino acids, myristoylated). Upon synthesis, the precursor GP-C is cleaved by cellular enzymes into its subunits, followed by glycosylation critical for folding and transport. Structural studies show that GP2 adopts a typical class I fusion protein architecture after pH-induced conformational change in the endosome, driving fusion of the viral and host membranes. GP1 binds host receptors (e.g., α-dystroglycan for Old World arenaviruses), but New World arenaviruses use different—and sometimes poorly characterized—receptors. The GP complex is the primary target of the neutralizing antibody response and the main component of experimental vaccines directed against arenavirus infections. The diversity and metastability of the GP1-GP2 interface pose challenges for the development of broadly protective immunogens and therapeutics.
Inhibition of viral entry (antibodies or entry inhibitors bind GP1/GP2 and prevent host cell attachment/fusion); Neutralization (antibodies bind exposed epitopes, block receptor engagement/fusion)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arenavirus envelope glycoprotein complex (GP-C).